학술논문
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies
Document Type
article
Author
Source
AIDS Research and Therapy, Vol 21, Iss 1, Pp 1-9 (2024)
Subject
Language
English
ISSN
1742-6405
Abstract
Abstract Background As the population of people with HIV ages, concerns over managing age-related comorbidities, polypharmacy, immune recovery, and drug-drug interactions while maintaining viral suppression have arisen. We present pooled TANGO and SALSA efficacy and safety results dichotomized by age (